St. Louis FDA laboratory DOGE said would close will stay open
A federal pharmaceutical testing facility in St. Louis will remain open, despite appearing on DOGE’s list of scheduled office ...
GEN - Genetic Engineering and Biotechnology News6d
StockWatch: Trump’s FDA Nominee Eyes Rare Disease-Specific Review Pathways
President Donald Trump’s nominee for FDA Commissioner, Martin A. Makary, MD, sought to assure senators that if confirmed, he would support efforts to expedite reviews of new drugs indicted for rare ...
BioSpace9d
Anxious Industry Awaits Makary’s Hearing Amid Disruptions, Layoffs at FDA
The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...
BioSpace8d
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.
The Hill19d
Pfizer hires ex-FDA drug chief as top doctor
Patrizia Cavazzoni was formerly director of the FDA’s Center for Drug Evaluation and Research (CDER) from 2020 until January, when she resigned just ahead of President Trump’s return to office.
Pfizer hires ex-FDA drug chief as top doctor
The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director of the ...
FierceBiotech19d
Ex-CDER chief Patrizia Cavazzoni becomes Pfizer’s chief medical officer
Trump has made major cuts across several federal health agencies—including the FDA—in the name of government efficiency, resulting in thousands of layoffs. After taking the top spot at CDER ...
The Daily Signal25d
FDA’s ‘Drug Safety Priorities’ Working Group Politicized Under Biden Administration
Per the FDA: The DRMB is a cross-CDER governance board responsible for three key objectives: (1) facilitating and coordinating decisions around major product safety issues, (2) providing clear and ...
STAT4d
Pharmalittle: We’re reading about Lilly and Roche weight loss drugs, FDA and compounders, and more
Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...
STAT20d
Patrizia Cavazzoni, former head of FDA’s drug center, joins Pfizer as chief medical officer
Cavazzoni was the head of the FDA’s Center for Drug Evaluation and Research (CDER), from 2020 until her departure in January. She was one of several top FDA officials who left the agency ahead ...
FiercePharma19d
In letter to RFK Jr., Democrats flag threats to drug review process from FDA firings
The user fee program framework includes trigger rates that must be met in order for the FDA to access the funding. Without enough staff at the CDER, which receives user fees, the FDA could find ...
pharmaphorum19d
Ex-CDER chief Cavazzoni rejoins Pfizer as CMO
Pfizer has hired the former director of the FDA's Center for Drug Evaluation and Research (CDER), Patricia Cavazzoni, as its new chief medical officer. Cavazzoni – who resigned just ahead of ...